Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins.
about
Endonuclease G promotes cell death of non-invasive human breast cancer cellsHER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cellsTenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1Differential gene expression in breast cancer cell lines and stroma-tumor differences in microdissected breast cancer biopsies revealed by display array analysis.Recruitment of CD34(+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis.Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma.Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells.Breast cancer with neoductgenesis: histopathological criteria and its correlation with mammographic and tumour features.Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.The progression of haze formation in rabbit corneas following phototherapeutic keratectomy.Defining the origins of Ras/p53-mediated squamous cell carcinomaInterleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen-urokinase plasminogen activator receptor system-regulated secretion during breast cancer progressionDiscovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy.Tenascin C in metastasis: A view from the invasive frontEpithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stromaDifferential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissuesVimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomasMDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics.Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell linesCripto-1: a multifunctional modulator during embryogenesis and oncogenesis.Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.Characterization of breast cancer interstitial fluids by TmT labeling, LTQ-Orbitrap Velos mass spectrometry, and pathway analysis.Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells.The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer.How do tenascins influence the birth and life of a malignant cell?Stromal biomarkers in breast cancer development and progression.The EMT signaling pathways in endometrial carcinoma.Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury.Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbetaJNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes.Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion.Biphasic metaplastic sarcomatoid carcinoma of the breast.Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells.Multicomponent analysis of the tumour microenvironment reveals low CD8 T cell number, low stromal caveolin-1 and high tenascin-C and their combination as significant prognostic markers in non-small cell lung cancer.A poorly differentiated pulmonary squamous cell carcinoma in a free-ranging Atlantic bottlenose dolphin (Tursiops truncatus).
P2860
Q24672656-B3FC7B17-5A4B-4596-BEAB-5428444E62F7Q25257668-1CA69BF2-20C6-47C7-8FF9-AD20E7CEED57Q28771732-BA4DC92E-8E3A-44E6-9D92-22A628F0D411Q32157249-8317202F-BBBA-4D88-9842-76FF6D848A17Q33708683-23290EEA-6F14-4EA5-878F-8856FF9609EFQ33824237-FB12FD4B-2556-4E00-8EA9-0F3F7DDE67E3Q33875853-428D7E74-F5C1-48ED-AFE4-B84C9EDDFD69Q33945493-C2919A96-B3C3-479E-9719-A76AEFC208B6Q34454213-57576A63-1170-431D-B55D-626687DDC223Q34461481-07DEF5E6-0884-47C4-8483-EE2DFC7B63DCQ34783977-FC358FA9-16DA-49EE-9582-FBDA34B73B8EQ34937383-AB87FD68-E37B-4863-AC31-96EB940C533BQ34999819-A97C5415-D1FE-42A9-89B1-FC613B44E909Q35144433-774E8786-18CF-4D19-A809-D2B0A81617A4Q35577928-4A98A18C-6420-44A4-9AA7-DB7AB0BF02DBQ35748940-C4D3419F-E017-480D-A9AA-011AF1FF54BFQ35789355-EDA68026-3D29-4C1E-93E2-26B5666CB648Q35984566-9D85D67C-F90A-4068-AB28-BD33DB54E7ACQ36027061-414AD4C4-B99A-4DEA-9908-359338B26729Q36070908-202F4F1B-B9F4-434A-98CD-BE9D1BAAEB7AQ36241244-464C0AA7-0371-48B3-8362-321D006B0078Q36338003-64E73FBB-C8F6-4B17-A035-AC0ABAEF5671Q36581928-AE7CBAE5-7308-427F-B17C-4453FD3C7A72Q36611431-F5C9DBF4-DB32-463B-84E0-F6E4CAC7BD26Q36965068-2F3AD72E-644A-4E7A-8950-AA7E5F2494EDQ37295200-34636CED-74A1-43B7-87F8-8D3367CFA7BAQ38017601-7318FDF8-8C4D-44DF-B1FA-2904FC3693A3Q38036605-1AC04140-1B9A-4367-BEB6-03480D776148Q38385221-B49D4095-46D5-4911-9ADC-D7CF451FEB19Q38594699-065659A3-6373-464F-9056-3810635EB252Q39331254-8B5EBFCE-470A-4A0A-B1B4-30C04B9AB624Q40229029-C821A6CC-994D-4457-B5A0-ABD65D6BB4CAQ40487608-7A1E8E23-FE01-49F0-A3A3-B14E43D6337EQ42680108-53DD05D9-0AE6-4300-9FC4-9C2D8989AF53Q47677944-57391041-BED9-43C5-9448-3440B211D5B2Q49882372-EA767F5C-490B-4D45-913F-0B9ED7ECB45AQ53657263-9436F0BA-18B9-455B-9489-DC2AA87D2683
P2860
Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Co-expression of tenascin-C an ...... e receptors, and oncoproteins.
@en
type
label
Co-expression of tenascin-C an ...... e receptors, and oncoproteins.
@en
prefLabel
Co-expression of tenascin-C an ...... e receptors, and oncoproteins.
@en
P2093
P2860
P1476
Co-expression of tenascin-C an ...... e receptors, and oncoproteins.
@en
P2093
Dandachi N
Hauser-Kronberger C
Wiesener B
P2860
P304
P356
10.1002/1096-9896(2000)9999:9999<::AID-PATH752>3.0.CO;2-V
P577
2001-02-01T00:00:00Z